ORLY vs RXRX · P/E 34, rev $9.45B vs rev $14.1M
O’Reilly Automotive Inc (ORLY) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported ORLY revenue for 2026-06-30 was $9.45B. Net income was $1.32B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
ORLY currently screens at market cap $78.32B and trailing P/E 33.7. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the ORLY and RXRX stock pages for the full models.
Not investment advice.